Platinum

Constellium Releases 2023 Sustainability Report

Retrieved on: 
Wednesday, March 20, 2024
Carbon, Community, Electricity, CDP, Carbon Disclosure Project, Climate change, Woman, Environment, Recycling, GHG, CSTM, Light, Neuf-Brisach, GRI, Safety, Sustainability, Platinum, Constellium, Commercial code, AA

PARIS, March 20, 2024 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) today announced the release of its 2023 Sustainability Report.

Key Points: 
  • PARIS, March 20, 2024 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) today announced the release of its 2023 Sustainability Report.
  • “Constellium has continued to make strides in its sustainability journey, despite a challenging environment and the continued impact of the energy crisis in Europe”, said Jean-Marc Germain, CEO of Constellium.
  • The report details Constellium’s sustainability performance in 2023, including:
    Safety: We delivered best-in-class safety performance in 2023, with a recordable case rate of 1.95 per million hours worked vs. a target of 1.5 in 2025, a slight increase vs. our 2022 results of 1.85.
  • Constellium’s 2023 Sustainability Report details the company's initiatives and results and is organized and presented in accordance with the Global Reporting Initiative’s (GRI) Sustainability Reporting Standards.

Canadian North Resources Reports Substantial Increase of Copper, Nickel, Cobalt, Palladium and Platinum NI 43-101 Compliant Mineral Resources for its 100% owned Ferguson Lake Project in Canada

Retrieved on: 
Tuesday, March 19, 2024
Leapfrog, Technical report, National Instrument 43-101, SRK, PGO, Ferguson Lake, Mineral Resources Limited, Classification, Gold, Copper, News, Strike, NSR, Security (finance), National instrument, Palladium, Mineral, Nickel, Rhodium, NI 43-101, Platinum, CIM, PGM, Cobalt, Resource, Uranium mining

TORONTO, March 19, 2024 (GLOBE NEWSWIRE) -- Canadian North Resources Inc. (“Canadian North” or the “Company”) (TSXV: CNRI; OTCQX: CNRSF; FSE: EO0 (E-O-zero)) is pleased to announce an updated Mineral Resource estimate (Table 1) for its 100% owned Ferguson Lake base metal (copper, nickel, cobalt) and platinum group metal (“PGM”, mainly palladium and platinum) project in Nunavut, Canada.

Key Points: 
  • This new Mineral Resource Estimate has demonstrated the project is one of the largest and highest-grade undeveloped critical mineral projects in North America.
  • The Mineral Resources for the Ferguson Lake Project were estimated using Leapfrog Edge™ software.
  • Open pit Mineral Resources are reported at a NSR cut-off value of US$33.00 and underground mineral resources are reported at a NSR cut-off value of US$96.00.
  • The 2022 Mineral Resource Estimate considered recoveries derived from hydrometallurgical testworks to produce the metal products of copper, nickel, cobalt, palladium and platinum.

Solo.io to Accelerate Digital Transformation Initiatives in the Enterprise with Exclusive Service Mesh Enhancement

Retrieved on: 
Tuesday, March 19, 2024
Diamond, CIO, Cilium, Organization, Amazon, Blog, Running, AWS Lambda, AWS, Architecture, Investment company, Amazon Web Services, Gold, Platinum, Online shopping

This release fast-tracks enterprise service-mesh adoption while delivering remarkable cost savings of up to 80% for existing Istio users.

Key Points: 
  • This release fast-tracks enterprise service-mesh adoption while delivering remarkable cost savings of up to 80% for existing Istio users.
  • “By enabling sidecarless deployments of Istio, we’re able to deliver greater simplicity, efficiency, and cost savings to Amazon EKS, AWS Lambda, and Amazon EKS Anywhere users, we’re empowering organizations to accelerate their digital transformation journey.
  • In addition, users can significantly reduce the complexities and costs of deploying and maintaining upstream open-source service mesh by up to 80%.
  • By combining efficient, cost-effective resource utilization with streamlined deployment processes, organizations can leverage Amazon EKS more effectively to accelerate cloud digital transformation initiatives.

Solo.io Unveils Spotlight Developer Platform to Accelerate Cloud-Native Development in the Enterprise

Retrieved on: 
Tuesday, March 19, 2024
Diamond, RBAC, Cilium, Organization, Documentation, IDP, Communication, Trust, Software, Multi, Backstage, SSO, Ecosystem, Gold, API, Platinum, Engineering, Video game

An enterprise-grade distribution based on the open source IDP, Backstage, Spotlight provides a comprehensive platform for developers to access services, software components, and tools throughout the software development lifecycle.

Key Points: 
  • An enterprise-grade distribution based on the open source IDP, Backstage, Spotlight provides a comprehensive platform for developers to access services, software components, and tools throughout the software development lifecycle.
  • According to Gartner, Inc. , 80% of large software engineering organizations will establish platform engineering teams as internal providers of reusable services, components and tools for applications.
  • This proliferation can be attributed in part to organizations recognizing the need for enhanced developer workflows, experience, and delivery speed.
  • With Solo.io’s Spotlight Developer Platform, we're streamlining that process and dramatically shortening the time to value in an effort to accelerate our customers’ journey toward engineering excellence.”
    With Spotlight Developer Platform, Solo.io addresses the complexity that comes with scaling development and operations in cloud-native environments.

PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer

Retrieved on: 
Monday, March 18, 2024
Ovarian cancer, Mutation, Serum, Patient, Pharming, SGO, Gynecologic Oncology (journal), Platinum, Pharmaceutical industry

Rezatapopt is a first-in-class precision oncology small molecule investigational therapy that selectively targets the TP53 Y220C mutation in solid tumors.

Key Points: 
  • Rezatapopt is a first-in-class precision oncology small molecule investigational therapy that selectively targets the TP53 Y220C mutation in solid tumors.
  • These data were featured today in a late-breaking oral presentation at the 2024 Society for Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer being held March 16-18, 2024 in San Diego, CA.
  • “In this Phase 1 study, we observed promising efficacy of rezatapopt in heavily pre-treated patients with advanced ovarian cancer harboring a TP53 Y220C mutation.
  • Our registrational, tumor-agnostic PYNNACLE Phase 2 trial, which includes an ovarian cancer cohort, remains on track to initiate in the first quarter of this year.

Rego Payment Architectures, Inc. Announces Major Sponsorship of Annual Q2 Customer Event

Retrieved on: 
Monday, March 18, 2024
CONNECT, Fairmont Hotel, BLUE, COPPA, Platinum, Parent, Cryptocurrency

This year’s CONNECT 24 will be held at the Fairmont Hotel in Austin, TX from June 4 to June 6 of 2024.

Key Points: 
  • This year’s CONNECT 24 will be held at the Fairmont Hotel in Austin, TX from June 4 to June 6 of 2024.
  • As mentioned in a previous announcement , REGO’s youth banking platform is integrated with Q2’s Digital Banking Platform, via the Q2 Partner Accelerator Program.
  • “We are excited to be a Platinum sponsor of Q2’s CONNECT 24 event this year,” said Peter S. Pelullo, CEO of REGO.
  • REGO’s sponsorship of the CONNECT 24 event will provide an opportunity for the company to showcase its unique COPPA-certified platform to financial institutions in attendance.

American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Against Kidney Disease

Retrieved on: 
Friday, March 15, 2024
American Kidney Fund, Candid (organization), Disease, Caregiver, Vertex Pharmaceuticals, Risk, GSK, Boehringer Ingelheim, GSK plc, Kidney disease, AKF, Therapy, Kidney, Eli Lilly and Company, Platinum, Charity Navigator, Corporation, Pharmaceutical industry

ROCKVILLE, Md., March 15, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is pleased to announce its 2024 Class of Corporate Members who serve as strategic partners in AKF’s Corporate Membership Program .

Key Points: 
  • ROCKVILLE, Md., March 15, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is pleased to announce its 2024 Class of Corporate Members who serve as strategic partners in AKF’s Corporate Membership Program .
  • Corporate Members provide essential support to AKF as it continues its fight against kidney disease on all fronts—from prevention through post-transplant living.
  • “Our Corporate Members—both new and returning—help make the work AKF does for the kidney community possible,” said LaVarne A. Burton, AKF President and CEO.
  • Corporate Members fund AKF’s essential work, including:
    Award-winning, evidence-based kidney health education resources that reach millions of people living with kidney disease, caregivers, living organ donors and health care providers each year
    The Corporate Membership Program is open to institutional partners that support AKF’s mission of fighting kidney disease and helping people live healthier lives.

Nuvectis Pharma Announces Encouraging Preliminary Data from the NXP800 Phase 1b Clinical Trial in Platinum-Resistant ARID1a-Mutated Ovarian Cancer

Retrieved on: 
Thursday, March 14, 2024
Bevacizumab, Ovarian cancer, Disease, Patient, Malignancy, Clinical trial, Fourth grade, Platinum, Thrombocytopenia, Food, Pharmaceutical industry

Fort Lee, NJ, March 14, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) today announced preliminary data from the ongoing Phase 1b clinical trial of NXP800 in patients with platinum resistant ARID1a-mutated ovarian cancer, a deadly disease of unmet medical need. The NXP800 development program in this disease was granted Fast Track Designation by the U.S. Food and Drug Administration (“FDA”). The Phase 1b clinical trial is being conducted in top clinical centers in the United States and the United Kingdom.

Key Points: 
  • Fort Lee, NJ, March 14, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) today announced preliminary data from the ongoing Phase 1b clinical trial of NXP800 in patients with platinum resistant ARID1a-mutated ovarian cancer, a deadly disease of unmet medical need.
  • The NXP800 development program in this disease was granted Fast Track Designation by the U.S. Food and Drug Administration (“FDA”).
  • The Phase 1b clinical trial is being conducted in top clinical centers in the United States and the United Kingdom.
  • Ron Bentsur, Chairman and Chief Executive Officer of Nuvectis, commented, “We are pleased to share the preliminary results from the NXP800 Phase 1b study in the target patient population of platinum resistant, ARID1a-mutated ovarian cancer patients.

North Bay Resources Announces Exploration at Murex Copper; Targets Historic Drill Holes up to 16m @ 6.1g/t Gold and Surface Samples up to >100g/t Gold

Retrieved on: 
Wednesday, March 13, 2024
Molybdenum, National Instrument 43-101, Nutrient, Vein, Geology, Magnesium, Murex, Fracture, Copper, Columbia, Gold, News, Imperial, Quartz, Tulameen, NBRI, National instrument, Carbon, Metal, Nickel, Imperial Metals, Autumn, CO2, OTC, Estate, Platinum, Magnesium oxide, Standard Oil, Cobalt, Press release, Mining, Sintering

The Company aims to further delineate the mineralized zones and begin the process of bringing the project compliant with modern exploration standards.

Key Points: 
  • The Company aims to further delineate the mineralized zones and begin the process of bringing the project compliant with modern exploration standards.
  • Extensive historical exploration by Standard Oil in the 1970’s and Noranda (Glencore), in the 1980’s, has provided a wealth of detailed data and information.
  • Large intersections of gold in drill core up to 16m @ 6.1g/t gold have also been identified.
  • In addition, historical surface samples from these zones are provided below showing significant gold and copper assays over large areas.

Solo.io Announces General Availability of Gloo Network for Cilium to Streamline Integration Across Hybrid Cloud Environments

Retrieved on: 
Wednesday, March 13, 2024
Diamond, Organization, Growth, CNCF, Ecosystem, Gold, Platinum, EBPF

“Cilium is helping reshape the future of cloud native networking thanks to its innovative capabilities and vibrant ecosystem.

Key Points: 
  • “Cilium is helping reshape the future of cloud native networking thanks to its innovative capabilities and vibrant ecosystem.
  • But deploying upstream Cilium has proven to be a complex endeavor for organizations,” said Idit Levine, CEO and Founder of Solo.io.
  • “With Gloo Network for Cilium, we’re enabling organizations to maximize their cloud networking potential by removing the complexity and providing access to our world-class support team to ensure their ongoing success.
  • Gloo Network for Cilium also seamlessly integrates with Gloo Mesh Core making it ideal for organizations transitioning to service mesh.